SLC5A2 and type 1 diabetes mellitus: In addition, as described above, there is some concern about diabetic ketoacidosis caused by SGLT2 inhibitors, and thus we should bear in mind the possibility of diabetic ketoacidosis, especially in patients with T1DM.